How can we make enough vaccine for 2 billion people?

Credit: Unsplash

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Harry Kretchmer, Senior Writer, Formative Content


  • The World Health Organization and other groups want to make 2 billion doses of vaccine available for the globe’s poorest by late 2021.
  • Wealthier nations have already signed deals to secure multiple vaccinations for their populations.
  • Making billions of doses will take a global effort, requiring innovation, fast-track approvals and complex supply chains.

With the pandemic, the world’s focus has shifted to the creation of an effective vaccine. But once that vaccine is in place, the job of eradicating COVID is far from over. The next challenge will be getting that vaccine to the people who need it most, a project that requires the rapid creation of a vast global supply chain.

One of these plans, COVAX, is a scheme created to provide fast, equitable access to a COVID-19 vaccine around the world. COVAX is trying to raise sufficient funds to make 2 billion doses of effective vaccine available by late 2021.

But that goal could be missed if nations attempt to secure the majority of doses for themselves, which World Health Organization (WHO) Director-General, Tedros Adhanom Ghebreyesus, has called “vaccine nationalism.”

Coronavirus vaccine candidates
There are a number of different COVID-19 vaccines in development. Image: Nature

It starts in the lab

The first challenge is to make the vaccine, and it starts small. Around the world, COVID-19 is being grown in cells – kidney cells are commonly used – by teams developing coronavirus vaccines. These are cultured in vats called bioreactors.

Different types of vaccines need different amounts of virus to be produced. For instance, London’s Imperial College, which is working on an RNA-based genetic code vaccine, needs just 1 litre of virus for 200 million people. Conventional vaccines require thousands of litres.

While tiny amounts are needed for vaccine testing (a thousandth of a thousandth of a gram in the case of RNA), for at-risk global populations to be inoculated, vast material will be needed for many of the more than 100 “candidate” vaccine programmes to scale. https://www.youtube.com/embed/5opR6x6NMpQ?enablejsapi=1&wmode=transparent

Building alliances

“In the early stages of the programme, my team built a consortium with smaller manufacturers in the UK and the Netherlands to go from a three litre scale up to 200 litres,” Sandy Douglas from Oxford’s Jenner Institute tells the BBC. But the team realized they had to get even bigger.

For the Oxford vaccine – among the furthest advanced potential treatments – partnering with pharmaceutical giant AstraZeneca enabled capacity to be increased significantly, adding hundreds of staff to work on the vaccine. Four bioreactors, each with a 2,000-litre capacity, will allow the production of a billion doses of vaccine in two months, the Economist reports. coronavirus, health, COVID19, pandemic

What is the World Economic Forum doing to manage emerging risks from COVID-19?

The first global pandemic in more than 100 years, COVID-19 has spread throughout the world at an unprecedented speed. At the time of writing, 4.5 million cases have been confirmed and more than 300,000 people have died due to the virus.

As countries seek to recover, some of the more long-term economic, business, environmental, societal and technological challenges and opportunities are just beginning to become visible.

To help all stakeholders – communities, governments, businesses and individuals understand the emerging risks and follow-on effects generated by the impact of the coronavirus pandemic, the World Economic Forum, in collaboration with Marsh and McLennan and Zurich Insurance Group, has launched its COVID-19 Risks Outlook: A Preliminary Mapping and its Implications – a companion for decision-makers, building on the Forum’s annual Global Risks Report.

The report reveals that the economic impact of COVID-19 is dominating companies’ risks perceptions.

Companies are invited to join the Forum’s work to help manage the identified emerging risks of COVID-19 across industries to shape a better future. Read the full COVID-19 Risks Outlook: A Preliminary Mapping and its Implications report here, and our impact story with further information.

However, even AstraZeneca isn’t doing all the work alone. Its partners include the Serum Institute of India, which is preparing to manufacture 1 billion doses of the Oxford vaccine. Other potential vaccines in China and the US are also progressing quickly thanks to complex partnerships. https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-0&frame=false&hideCard=false&hideThread=false&id=1296031492703948802&lang=en&origin=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F08%2Fcovid-vaccine-manufacture-distribute-2-billion-doses%2F&theme=light&widgetsVersion=223fc1c4%3A1596143124634&width=550px

Working together and innovating

There are currently around 30 candidate vaccines at the more advanced “clinical evaluation” stage and almost 140 more in pre-clinical evaluation, according to the WHO.

Some vaccines could require multiple doses, meaning that potentially 4 billion doses could be needed for the most vulnerable.

Such volume can be more easily reached if companies work together. “No pharma company could make 5 billion doses in the next year or so,” Stéphane Bancel, CEO of biotech company Moderna tells the World Economic Forum’s COVID Action Platform. “But if several of us get to the finish line, then we should be able to put a big dent in the spread of the virus.”

How the vaccine is made can also facilitate fast manufacture at scale. The Oxford trial is employing “single use technologies” – essentially making vaccines in disposable plastic bags – Sandy Douglas tells the BBC. This has made production much easier and less vulnerable to shortages of glassware and other products.

“We need hundreds or thousands of input materials and a shortage of any one of them could derail the whole thing,” says Douglas. To make the supply chain as robust as possible, his team has made sure alternative components can be substituted in if needed.

The COVAX project aims to make 2 billion doses available to the world’s poorest people.
The COVAX project aims to make 2 billion doses available to the world’s poorest people. Image: Gavi

Delivering where it’s needed most

But making a vaccine in record time will be of limited use if the people who need it most are denied access. This is the concern and motivation behind COVAX, the project led by the WHO, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI).

The programme is designed to pool funds from wealthy nations and nonprofits to develop and distribute a COVID-19 vaccine equitably. It is aiming to deliver 2 billion approved doses by late 2021. The idea is that high-income countries buy vaccines through COVAX and poorer, “funded” countries receive financial assistance.

However, last month the WHO warned that its $2 billion funding target was some way off being met, with around $600 million having been raised and not enough nations signing up.

At the same time, some nations have spent billions of dollars on deals with multiple manufacturers, securing hundreds of millions of doses for their own use.

“We need to prevent vaccine nationalism,” says Tedros Adhanom Ghebreyesus. “As we accelerate the science, solidarity is needed to provide a joint solution to the pandemic.”

Making 2 billion vaccine doses will be an extraordinary achievement; putting them to the best use could be another.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

4 eco-friendly products put sustainable spins on classic practices, from teacups to hankies

Parliament proposes policy toolbox to curb air pollution

EU Cohesion policy: Commission adopts €21 billion Greek Partnership Agreement for 2021-2027

UN welcomes Angola’s repeal of anti-gay law, and ban on discrimination based on sexual orientation

The fatal consequences of troika’s blind austerity policy

Protecting migratory species in a rapidly changing world

Companies that put employees first perform better

Prejudice-based medicine

Egyptian death sentences a ‘gross miscarriage of justice’: UN human rights chief

Palliative care and UHC in India: Still Uncharted Waters?

EU Commission announces Safe Harbour 2.0 and a wider Data protection reform

Traffic congestion cost the US economy nearly $87 billion in 2018

How we can win the war against antibiotic resistance

EU sets ambitious targets for the Warsaw climate conference

Mental health in medical students: the deciphered quandary

‘Jerusalem is not for sale’ Palestinian President Abbas tells world leaders at UN Assembly

India’s mega-rich are on the rise

Funding boost for sustainable development data agreed at UN conference

Dieselgate: Parliament calls for mandatory retrofits of polluting cars

Human rights breaches in Nigeria and Burundi

Moving from a promise made in Sweden towards hope for peace in Yemen

Ignorance or Refusal: Determinants in the individual’s choice for palliative care

Future Forces Forum: Prague will be hosting the most important project in the field of Defence and Security

To achieve the Great Reset, we will need more than just the actions of the powerful

Alternative proteins will transform food, mitigate climate change and drive profits. Here’s how

GSMA Mobile 360 Series – Europe – 14 June 2016

Antibiotics are contaminating the world’s rivers

This is how wellbeing drives social change and why cultural leaders need to talk about it

‘Unique opportunity’ to resolve border dispute between Sudan, South Sudan

Erasmus+: over €28 billion to support mobility and learning for all, across the European Union and beyond

Europe had a record year for Measles – and it’s partly down to anti-vaccine campaigners

Human rights breaches in Hong Kong, Russia and at the US-Mexican border

How governments can redesign support for entrepreneurs after COVID-19

What little Cameron got in Brussels seems enough to keep Britain in the EU

Climate change will be sudden and cataclysmic. We need to act fast

Athens urged to fast track asylum seekers amid island shelters crisis – UNHCR

EU-Vietnam trade agreement enters into force

Apparently the EU Digital Single Market passes necessarily from China’s Digital Silk Road

FROM THE FIELD: facing up to the extreme mental health pressures of conflict

Facebook: MEPs demand a full audit by EU bodies to assess data protection

Can Southeast Asia keep up with growing energy demand?

Religious violence is on the rise. What can faith-based communities do about it?

Draghi to hold on zero interest rates until he leaves ECB

Employment and Social Developments in Europe: 2019 review highlights that tackling climate change can be a driver for growth and jobs

Coronavirus variants: Commission calls for limiting essential travel from India

World Retail Congress Dubai 2016: Retail’s night of nights

Global Cooperation for Local Action: Fighting antimicrobial resistance

GSMA Introduces MWC21 Travel Partner Gray Dawes

EU Budget 2019: no deal before the end of the conciliation period

The Indian miracle state pointing the way to global sustainability

Amid ongoing fighting in northeast Syria, hundreds cross Iraqi border in search of safety

Poorer countries set to be ‘increasingly dependent’ on food imports, says UN food agency report

230 Junior Entrepreneurs and over 70 guests attended the International Congress on “Entrepreneurial Skills for Youth”

Summer pause gives time to rethink Eurozone’s problems

At last Britain considers a super-soft Brexit

Towards a tobacco free India

UN chief encourages victims of terrorism to ‘raise up their voices’

This Latin American country is keeping COVID-19 firmly under control. How?

‘Nothing left to go back for’: UN News hears extraordinary stories of loss, and survival as Mozambique rebuilds from deadly cyclones

This young activist explains how to change the world in 3 steps

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s